ImmunOs Therapeutics raised $74m in Series B funding backed by Samsara BioCapital, Lightspeed Venture Partners and Gimv

Biotech Health services Pharma

Investments

05 June 2022

ImmunOs Therapeutics (company)

Biotech Health services Pharma

Total investments received (USD): 85m

Round value (USD): 74m

Round investors: BioMedPartners Gimv Lightspeed Venture Partners Pfizer Venture Investments Schroder Adveq Samsara BioCapital PEAK6 Investments Mission BioCapital

Industry: Biotech Health services Pharma

Biotech Health services Manufacturing

Investments 08 April 2022

Biotech Health services

Investments 07 April 2022